Get the app →
BriefTea logoBriefTea

Every story in sixty words

Get the free app no ads · no paywall

Explained in plain English

Europe's first daily pill?

Foundayo is highlighted as Europe's first approved daily pill for obesity and type 2 diabetes. This signifies a new type of treatment option for these conditions. While other treatments exist, including injectables, a daily pill could offer a more convenient and potentially more accessible option for many people across Europe.

Stories that explain this

Foundayo, Eli Lilly's new daily pill, approved for UK weight loss

Related explainers

Who is Eli Lilly? Will the NHS pay for it? What are weight loss jabs? Why is UK first in Europe? Is 42 a typical age for first baby? How does ADHD affect daily life? Why build EVs in Europe? Why cut managers first?

The full catalogue

Browse every card filed under E →